In breast cancer cells, PMEPA1 could be upregulated by classical TGF-β/Smad signaling pathway, and silencing of PMEPA1 significantly could inhibit the migration ability of MDA-MB-231 cells and promoted the process of EMT. Here, PMEPA1 is linked to breast cancer.